Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors. (Q55475153)
Jump to navigation
Jump to search
scientific article published in July 2000
Language | Label | Description | Also known as |
---|---|---|---|
English | Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors. |
scientific article published in July 2000 |
Statements
Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors. (English)
1 reference
Trojanowski JQ
1 reference
Grotzer MA
1 reference
Janss AJ
1 reference
Phillips PC
1 reference
1 July 2000
1 reference
212
1 reference
4
1 reference
196-199
1 reference